Across 75 twelve-week dietary intervention periods on a metabolic-ward cohort, varying fat quality (35% of calories as saturated vs. polyunsaturated fat) and dietary cholesterol quantity, about 69% of subjects compensated for added dietary cholesterol by down-regulating fractional cholesterol absorption and/or endogenous (whole-body) cholesterol synthesis, holding plasma cholesterol nearly flat. The remaining ~31% failed to suppress synthesis adequately and showed a plasma-cholesterol rise. Averaged across the cohort, fat quality was a larger driver of plasma cholesterol than cholesterol quantity.
relevance_note: Supplies the physiological mechanism behind hypo- vs. hyper-responder status (absorption/synthesis feedback that works in most people, fails in a minority) — the “how” underneath Katan & Beynen’s “that.”
Methodology
Metabolic-ward controlled feeding across 75 twelve-week diet periods. Each period supplied 35% of calories as either saturated or polyunsaturated fat, tested first low and then high in dietary cholesterol. During every period the study measured dietary fat and cholesterol intake, plasma lipid and lipoprotein levels, cholesterol fractional absorption, and sterol synthesis in isolated blood mononuclear leukocytes (a proxy for whole-body endogenous synthesis). Depth-limited read: the full text is accessible only as scanned page images, so exact subject n and per-dose cholesterol amounts are not recoverable; extraction rests on the verbatim abstract plus the step-2 node summary.
Results
O-1 - 69% of metabolic-ward diet periods compensated for added dietary cholesterol; ~31% showed a plasma-cholesterol rise
Direct-measurement metabolic-ward design: fractional cholesterol absorption and sterol synthesis (in isolated blood mononuclear leukocytes) were measured in each of 75 twelve-week diet periods, alongside plasma lipids. The 69/31 split is a per-period compensation frequency, not a per-subject genotype count (exact subject n not recoverable from the accessible text). Depth-limited: full text is available only as scanned page images; extraction rests on the abstract plus the step-2 node summary.
Link to originalMethodology
Metabolic-ward controlled feeding across 75 twelve-week diet periods. Each period supplied 35% of calories as either saturated or polyunsaturated fat, tested first low and then high in dietary cholesterol. During every period the study measured dietary fat and cholesterol intake, plasma lipid and lipoprotein levels, cholesterol fractional absorption, and sterol synthesis in isolated blood mononuclear leukocytes (a proxy for whole-body endogenous synthesis). Depth-limited read: the full text is accessible only as scanned page images, so exact subject n and per-dose cholesterol amounts are not recoverable; extraction rests on the verbatim abstract plus the step-2 node summary.
Link to original
O-2 - Plasma-cholesterol rise on added dietary cholesterol coincided with failure to suppress endogenous synthesis
An observed co-occurrence within the dataset: a plasma-cholesterol rise tracked the specific sub-set of periods lacking synthesis suppression. States the association only, not the causal direction.
Link to original
O-3 - Cohort plasma cholesterol more sensitive to dietary fat quality than to cholesterol quantity
A within-dataset comparison of the two manipulated dietary factors; scoped to this cohort and these dose ranges.
Link to original
Interpretation
H-1 - Plasma-cholesterol response to dietary cholesterol is highly individualized (hypo- vs hyper-responders)
The interpretive generalization from the 69/31 per-period split to a stable, individualized responder trait. Contestable: the split could partly reflect measurement variability or regression to the mean rather than a fixed phenotype.
Link to original
H-2 - Feedback down-regulation of absorption and synthesis buffers dietary cholesterol in most people
The mechanistic causal claim underneath the heterogeneity: that the observed absorption/synthesis down-regulation is the buffering cause, and that its failure is what produces the hyper-responder rise. Uncertain because it is a causal-mechanism interpretation of a co-occurrence.
Link to original
H-3 - Dietary fat quality is a larger determinant of plasma cholesterol than dietary cholesterol quantity
Generalization beyond this cohort of the within-dataset comparison. Bears on the egg question because it downweights egg-borne cholesterol relative to accompanying dietary fat.
Link to original
Arguments
A-1 - Rise coinciding with failed synthesis suppression against a compensating majority implies a feedback-control responder mechanism
Two facts have to be combined. First, in a majority of periods (69%) added dietary cholesterol produced little plasma change, and this coincided with measured down-regulation of fractional absorption and/or endogenous synthesis. Second, wherever plasma cholesterol did rise, it rose in exactly the periods where endogenous synthesis was NOT suppressed.
If the split were only measurement noise or regression to the mean, the plasma rise would not be systematically tied to a specific measured physiological state (unsuppressed synthesis); noise would scatter the rise across compensating and non-compensating periods alike. The observed alignment — rise ←> failed suppression, flat ←> successful suppression — is what a genuine feedback-control mechanism predicts and what pure variability does not. This upgrades the bare 69/31 frequency into evidence for (a) a real buffering mechanism operating through absorption/synthesis feedback (H-2) and (b) an individualized responder axis, since the mechanism succeeds in most people and fails in a minority (H-1). The inference is not airtight — the design measures synthesis in circulating leukocytes as a proxy for whole-body synthesis, and per-period rather than per-subject accounting leaves open how stable the phenotype is — but the mechanistic co-alignment is the non-obvious step that the raw split alone does not give.
Validity (step 6)
status: corrected, reason_if_not_false: checked.
Traced step. The load-bearing move is: a plasma rise that aligns systematically with one measured physiological state (unsuppressed synthesis) is what a feedback-control mechanism predicts and what noise/regression-to-mean does not (noise would scatter the rise across compensating and non-compensating periods alike). That step is sound — systematic tie of an outcome to a specific measured intermediate is genuine evidence for a mechanism over random variation. So the mechanism half of the conclusion (H-2, a real absorption/synthesis buffering mechanism) is approved as stated.
Where the as-stated claim over-reaches is the individualized responder axis / “governing who responds” half (H-1). O-1/O-2 are counted per diet-period, not per subject. An undercutting defeater survives without denying the premises: within-person, state-dependent variation in synthesis suppression (a person compensating in some periods and not others) reproduces the exact rise↔failed-suppression alignment with no stable person-level responder phenotype. The per-period design cannot separate a trait (who responds) from a state (when suppression happens to fail) — a limitation the body already concedes. Hence the step supports the mechanism but only weakly supports, and does not establish, individualization. Corrected to the weaker form; statement edited, pre-edit text preserved below.
Original
statement: “The plasma-cholesterol rise appearing specifically where synthesis suppression failed, set against a 69% compensating majority, supports an individualized feedback-control mechanism (not mere random variation) governing who responds to dietary cholesterol.”
Link to original